The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Acromegaly-Global Market Insights and Sales Trends 2025
Synopsis
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.
The global Acromegaly market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Acromegaly in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Acromegaly market. Somatostatin Analogues, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dopamine Agonists segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Acromegaly, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Acromegaly market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Acromegaly market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Acromegaly sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Acromegaly covered in this report include Novartis, Aegis Therapeutics, Chiasma, Crinetics Pharmaceuticals, Daewoong Pharmaceutical, Peptron, Silence Therapeutics, Strongbridge Biopharma and Amryt Pharma, etc.
The global Acromegaly market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Aegis Therapeutics
Chiasma
Crinetics Pharmaceuticals
Daewoong Pharmaceutical
Peptron
Silence Therapeutics
Strongbridge Biopharma
Amryt Pharma
Foresee Pharmaceuticals
Glide Pharmaceutical
Ionis Pharmaceuticals
Ipsen
Global Acromegaly market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Acromegaly market, Segment by Type:
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
Global Acromegaly market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Acromegaly companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults.
The global Acromegaly market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Acromegaly in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Acromegaly market. Somatostatin Analogues, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dopamine Agonists segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Acromegaly, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Acromegaly market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Acromegaly market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Acromegaly sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Acromegaly covered in this report include Novartis, Aegis Therapeutics, Chiasma, Crinetics Pharmaceuticals, Daewoong Pharmaceutical, Peptron, Silence Therapeutics, Strongbridge Biopharma and Amryt Pharma, etc.
The global Acromegaly market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Aegis Therapeutics
Chiasma
Crinetics Pharmaceuticals
Daewoong Pharmaceutical
Peptron
Silence Therapeutics
Strongbridge Biopharma
Amryt Pharma
Foresee Pharmaceuticals
Glide Pharmaceutical
Ionis Pharmaceuticals
Ipsen
Global Acromegaly market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Acromegaly market, Segment by Type:
Somatostatin Analogues
Dopamine Agonists
Growth Hormone Receptor Antagonists
Other
Global Acromegaly market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Acromegaly companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Acromegaly
1.1 Acromegaly Market Overview
1.1.1 Acromegaly Product Scope
1.1.2 Acromegaly Market Status and Outlook
1.2 Global Acromegaly Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Acromegaly Market Size by Region (2018-2029)
1.4 Global Acromegaly Historic Market Size by Region (2018-2023)
1.5 Global Acromegaly Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Acromegaly Market Size (2018-2029)
1.6.1 North America Acromegaly Market Size (2018-2029)
1.6.2 Europe Acromegaly Market Size (2018-2029)
1.6.3 Asia-Pacific Acromegaly Market Size (2018-2029)
1.6.4 Latin America Acromegaly Market Size (2018-2029)
1.6.5 Middle East & Africa Acromegaly Market Size (2018-2029)
2 Acromegaly Market by Type
2.1 Introduction
2.1.1 Somatostatin Analogues
2.1.2 Dopamine Agonists
2.1.3 Growth Hormone Receptor Antagonists
2.1.4 Other
2.2 Global Acromegaly Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Acromegaly Historic Market Size by Type (2018-2023)
2.2.2 Global Acromegaly Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Acromegaly Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Acromegaly Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Acromegaly Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Acromegaly Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Acromegaly Revenue Breakdown by Type (2018-2029)
3 Acromegaly Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.2 Global Acromegaly Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Acromegaly Historic Market Size by Application (2018-2023)
3.2.2 Global Acromegaly Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Acromegaly Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Acromegaly Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Acromegaly Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Acromegaly Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Acromegaly Revenue Breakdown by Application (2018-2029)
4 Acromegaly Competition Analysis by Players
4.1 Global Acromegaly Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acromegaly as of 2022)
4.3 Date of Key Players Enter into Acromegaly Market
4.4 Global Top Players Acromegaly Headquarters and Area Served
4.5 Key Players Acromegaly Product Solution and Service
4.6 Competitive Status
4.6.1 Acromegaly Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Acromegaly Products, Services and Solutions
5.1.4 Novartis Acromegaly Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Aegis Therapeutics
5.2.1 Aegis Therapeutics Profile
5.2.2 Aegis Therapeutics Main Business
5.2.3 Aegis Therapeutics Acromegaly Products, Services and Solutions
5.2.4 Aegis Therapeutics Acromegaly Revenue (US$ Million) & (2018-2023)
5.2.5 Aegis Therapeutics Recent Developments
5.3 Chiasma
5.3.1 Chiasma Profile
5.3.2 Chiasma Main Business
5.3.3 Chiasma Acromegaly Products, Services and Solutions
5.3.4 Chiasma Acromegaly Revenue (US$ Million) & (2018-2023)
5.3.5 Crinetics Pharmaceuticals Recent Developments
5.4 Crinetics Pharmaceuticals
5.4.1 Crinetics Pharmaceuticals Profile
5.4.2 Crinetics Pharmaceuticals Main Business
5.4.3 Crinetics Pharmaceuticals Acromegaly Products, Services and Solutions
5.4.4 Crinetics Pharmaceuticals Acromegaly Revenue (US$ Million) & (2018-2023)
5.4.5 Crinetics Pharmaceuticals Recent Developments
5.5 Daewoong Pharmaceutical
5.5.1 Daewoong Pharmaceutical Profile
5.5.2 Daewoong Pharmaceutical Main Business
5.5.3 Daewoong Pharmaceutical Acromegaly Products, Services and Solutions
5.5.4 Daewoong Pharmaceutical Acromegaly Revenue (US$ Million) & (2018-2023)
5.5.5 Daewoong Pharmaceutical Recent Developments
5.6 Peptron
5.6.1 Peptron Profile
5.6.2 Peptron Main Business
5.6.3 Peptron Acromegaly Products, Services and Solutions
5.6.4 Peptron Acromegaly Revenue (US$ Million) & (2018-2023)
5.6.5 Peptron Recent Developments
5.7 Silence Therapeutics
5.7.1 Silence Therapeutics Profile
5.7.2 Silence Therapeutics Main Business
5.7.3 Silence Therapeutics Acromegaly Products, Services and Solutions
5.7.4 Silence Therapeutics Acromegaly Revenue (US$ Million) & (2018-2023)
5.7.5 Silence Therapeutics Recent Developments
5.8 Strongbridge Biopharma
5.8.1 Strongbridge Biopharma Profile
5.8.2 Strongbridge Biopharma Main Business
5.8.3 Strongbridge Biopharma Acromegaly Products, Services and Solutions
5.8.4 Strongbridge Biopharma Acromegaly Revenue (US$ Million) & (2018-2023)
5.8.5 Strongbridge Biopharma Recent Developments
5.9 Amryt Pharma
5.9.1 Amryt Pharma Profile
5.9.2 Amryt Pharma Main Business
5.9.3 Amryt Pharma Acromegaly Products, Services and Solutions
5.9.4 Amryt Pharma Acromegaly Revenue (US$ Million) & (2018-2023)
5.9.5 Amryt Pharma Recent Developments
5.10 Foresee Pharmaceuticals
5.10.1 Foresee Pharmaceuticals Profile
5.10.2 Foresee Pharmaceuticals Main Business
5.10.3 Foresee Pharmaceuticals Acromegaly Products, Services and Solutions
5.10.4 Foresee Pharmaceuticals Acromegaly Revenue (US$ Million) & (2018-2023)
5.10.5 Foresee Pharmaceuticals Recent Developments
5.11 Glide Pharmaceutical
5.11.1 Glide Pharmaceutical Profile
5.11.2 Glide Pharmaceutical Main Business
5.11.3 Glide Pharmaceutical Acromegaly Products, Services and Solutions
5.11.4 Glide Pharmaceutical Acromegaly Revenue (US$ Million) & (2018-2023)
5.11.5 Glide Pharmaceutical Recent Developments
5.12 Ionis Pharmaceuticals
5.12.1 Ionis Pharmaceuticals Profile
5.12.2 Ionis Pharmaceuticals Main Business
5.12.3 Ionis Pharmaceuticals Acromegaly Products, Services and Solutions
5.12.4 Ionis Pharmaceuticals Acromegaly Revenue (US$ Million) & (2018-2023)
5.12.5 Ionis Pharmaceuticals Recent Developments
5.13 Ipsen
5.13.1 Ipsen Profile
5.13.2 Ipsen Main Business
5.13.3 Ipsen Acromegaly Products, Services and Solutions
5.13.4 Ipsen Acromegaly Revenue (US$ Million) & (2018-2023)
5.13.5 Ipsen Recent Developments
6 North America
6.1 North America Acromegaly Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Acromegaly Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Acromegaly Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Acromegaly Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Acromegaly Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Acromegaly Market Dynamics
11.1 Acromegaly Industry Trends
11.2 Acromegaly Market Drivers
11.3 Acromegaly Market Challenges
11.4 Acromegaly Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
